>would be interested to see what the new market share numbers are for MS market. Avonex seems to be growing nicely and tysabri is growing a little. is the overall market growing dramatically or is the market share for one of the other therapies decreasing?<
Worldwide market shares through 2Q08 are shown in #msg-31152081.
TEVA provides a chart of MS market-share data on its quarterly CC’s, so an update for 3Q08 should be available soon, which will additionally answer the question regarding overall market size.
<font size=3><font color=red> “The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”